110226 ⎘
Reverse transcribing DNA viruses; Details; Hepadnaviridae; Orthohepadnavirus, e.g. hepatitis B virus Virus like particles [VLP]
USE OF VIRUS-LIKE PARTICLES IN VACCINATION
#2METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION
#3METHODS AND COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B INFECTION
#4MULTI-ANTIGEN THERAPEUTIC VACCINES TO TREAT OR PREVENT CHRONIC HEPATITIS B VIRUS INFECTION
#5Universal vaccine platform
#6Methods and compositions for the treatment of hepatitis B infection
#7VLP stabilized vaccine compositions
#8VIRUS-LIKE PARTICLES AND METHODS OF PRODUCTION THEREOF
#9HEPADNAVIRUS CAPSID PROTEIN HETERODIMERS AND VIRUS-LIKE PARTICLES
#10ENGINEERED HEPATITIS B CORE POLYPEPTIDE
#11SUPERPARAMAGNETIC GOLD NANOPARTICLE CLUSTER-PROTEIN NANOPARTICLE FUSION BODY FOR MAGNETIC RESONANCE IMAGING AND MAGNETIC THERMOTHERAPY
#12Compositions and methods for generating an immune response to hepatitis B virus
#13HEPATITIS B VIRUS VACCINE AND USES THEREOF
#14Methods and compositions for the treatment of hepatitis B infection
#15CORONAVIRUS VACCINE AND METHODS OF USE THEREOF
#16Universal vaccine platform
#17Compositions and methods for treating viral infections
#18VLP stabilized vaccine compositions
#19Engineered hepatitis B core polypeptide
#20Non-immunogenic protein nanoparticles with cancer targeting activity using albumin-binding peptide
#21Virus-like particles comprising zika antigen
#22Virus-like particles including HBs-L antigen protein for causing immune response against HBV
#23Universal vaccine platform
#24Vaccine composition comprising hepatitis B virus like particle as adjuvant
#25Polypeptide carrier for presenting target polypeptide and uses thereof
#26Compositions and methods for generating an immune response to hepatitis B virus
#27Multivalent VLP conjugates
#28Recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine
#29ANTIBODY-VACCINE ENGINEERED CONSTRUCTS (AVEC)
#30Recombinant self-assembling protein comprising target-oriented peptide and use thereof
#31In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus-Like Particles
#32Multivalent VLP conjugates
#33Tumor vaccination involving a humoral immune response against self-proteins
#34VLP stabilized vaccine compositions
#35SPECIFIC VIRUS-LIKE PARTICLE-CpG OLIGONUCLEOTIDE VACCINES AND USES THEREOF
#36Methods for enumeration of rare cells
#37SPECIFIC MULTIVALENT VIRUS-LIKE PARTICLE VACCINES AND USES THEREOF
#38VIRUS-LIKE PARTICLE FOR USE IN IMMUNOASSAY, BLOCKING AGENT FOR USE IN THE IMMUNOASSAY, AND KIT COMPRISING THE VIRUS-LIKE PARTICLE AND THE BLOCKING AGENT
#39Recombinant self-assembling protein comprising target-oriented peptide and use thereof
#40Stabilized hepatitis B core polypeptides
#41IN VIVO ACTIVATION OF ANTIGEN PRESENTING CELLS FOR ENHANCEMENT OF IMMUNE RESPONSES INDUCED BY VIRUS-LIKE PARTICLES
#42Scalable process for protein purification
#43Tumor vaccination involving a humoral immune response against self-proteins
#44Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
#45Tumor vaccination involving a humoral immune response against self-proteins
#46HBV CORE ANTIGEN PARTICLES WITH MULTIPLE IMMUNOGENIC COMPONENTS ATTACHED VIA PEPTIDE LIGANDS
#47SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM
#48Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
#49Scalable Process for Protein Purification
#50Molecular Antigen Array
#51Scalable Process for Protein Purification
#52Molecular Antigen Array
#53SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM
#54In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like Particles
#55HEPATITIS VIRUS CORE PROTEINS AS VACCINE PLATFORMS AND METHODS OF USE THEREOF
#56Fusion proteins and use thereof for preparing hepatitis C vaccines
#57MELAN-A-CARRIER CONJUGATES
#58Angiotensin peptide-carrier conjugates and uses thereof
#59PACKAGED VIRUS-LIKE PARTICLES FOR USE AS ADJUVANTS: METHOD OF PREPARATION AND USE
#60Method for Efficient Purification of Bionanocapsule
#61HBV precore protein capable of forming particles
#62Vaccines for malaria
#63Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
#64RECOMBINANT PROTEINS AND VIRUS LIKE PARTICLES COMPRISING L AND S POLYPEPTIDES OF AVIAN HEPADNAVIRIDAE AND METHODS, NUCLEIC ACID CONSTRUCTS, VECTORS AND HOST CELLS FOR PRODUCING SAME
#65Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use
#66CELL-FREE SYNTHESIS OF VIRUS LIKE PARTICLES
#67VIRUS LIKE PARTICLES
#68Antigen Arrays for Treatment of Allergic Eosinophilic Diseases
#69Scalable process for protein purification
#70Bacteriophage-mediated immunisation against hepatitis
#71Molecular antigen arrary
#72Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use
#73Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use
#74Hepatitis virus core proteins as vaccine platforms and methods of use thereof
#75Carrier Conjugates Of Tnf-Peptides
#76HBV core antigen particles with multiple immunogenic components attached via peptide ligands
#77Hbv Particles Containing Hbv-Rna
#78Stabilized virus-like particles and epitope display systems
#79Antigen arrays for treatment of bone disease
#80Antigen arrays for treatment of allergic eosinophilic diseases
#81Angiotensin peptide-carrier conjugates and uses thereof
#82Viral deconstruction through capsid assembly in vitro
#83Molecular antigen array
#84Influenza immunogen and vaccine
#85Stabilized immunogenic HBc chimer particles
#86Self-assembling nanoparticle drug delivery system
#87Hollow nanoparticles of protein and drug using the same
#88Purification of viruses, proteins and nucleic acids
#89Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
#90Packaged virus-like particles
#91Hiv-peptide-carrier-conjugates
#92Melan-A- carrier conjugates
#93HBV precore protein capable of forming particles
#94Influenza immunogen and vaccine
#95Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
#96Hollow nanoparticle of NBsAg large protein for drug delivery
#97Angiotensin peptide-carrier conjugates and uses thereof
#98Ghrelin-carrier conjugates